CD276 and small cell lung carcinoma: Studies using small cohorts of SCLC have also found low expression of CTLA-4, T-cell immunoglobulin and ITIM domain (TIGIT), and other immunosuppressive molecules commonly targeted by ICIs, with increased expression of alternate checkpoints CD276 and CD200[56].